Janku Filip — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Janku Filip has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.38M.

Profile

Janku Filip

Filip Janku is the Chief Medical Officer of Monte Rosa Therapeutics, Inc. (ticker GLUE) per SEC filing (CIK 0001862930) with the most recent filing dated 2026-01-05. In this capacity, he leads medical strategy and clinical development for Monte Rosa’s molecular glue degrader programs. The filing indicates no equity purchases or sales by him in the reported period.

RoleInsider
Notability40/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-01GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale5.4K$24.50$132K
2026-07-01GLUEMonte Rosa Therapeutics, Inc.M — Option exercise5.4K$13.41$73K
2026-06-30GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale6.0K$22.95$138K
2026-06-30GLUEMonte Rosa Therapeutics, Inc.M — Option exercise6.0K$7.56$45K
2026-06-25GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale30.0K$21.42$643K
2026-06-25GLUEMonte Rosa Therapeutics, Inc.M — Option exercise30.0K$7.56$227K
2026-06-25GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale11.8K$20.22$240K
2026-06-25GLUEMonte Rosa Therapeutics, Inc.M — Option exercise6.0K$7.56$45K
2026-02-24GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale9.2K$19.50$179K
2026-01-05GLUEMonte Rosa Therapeutics, Inc.S — Open-market sale3.2K$15.17$48K
2026-01-05GLUEMonte Rosa Therapeutics, Inc.A — Grant or award31.0K—

Companies — Last 90 Days

Frequently Asked Questions

Who is Janku Filip?

Filip Janku is the Chief Medical Officer of Monte Rosa Therapeutics, Inc. (ticker GLUE) per SEC filing (CIK 0001862930) with the most recent filing dated 2026-01-05. In this capacity, he leads medical strategy and clinical development for Monte Rosa’s molecular glue degrader programs. The filing indicates no equity purchases or sales by him in the reported period.…

How many SEC Form 4 filings has Janku Filip submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Janku Filip been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 6 open-market sales ($1.38M) across all tracked filings.

Where can I see all of Janku Filip's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Janku Filip profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.